Chronic hepatitis C
- PMID: 17218670
- PMCID: PMC1767253
- DOI: 10.1136/bmj.39050.576644.80
Chronic hepatitis C
Abstract
Antiviral therapy is approved by NICE but too few patients receive it
Conflict of interest statement
References
-
- Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140:346-55. - PubMed
-
- National Institute for Health and Clinical Excellence. Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. London: NICE, August 2006. www.nice.org.uk/download.aspx?o=TA106guidance
-
- Department of Health. Hepatitis C: action plan for England. London: DOH, July 2004. www.dh.gov.uk/assetRoot/04/08/47/13/04084713.pdf
-
- Health Protection Agency. Hepatitis C in England: annual report. London: HPA, December 2006. www.hpa.org.uk/publications/2006/hepc_2006/Hepatitis_C2.pdf
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources